Riskpilot← Back to searchSign inGet full accessNoventus AB
ABActiveOrg 5565638847Henry Dunkers Plats 4Physiotherapy activities · NACE 8695Est. 19992 employees
Revenue 2025
SEK 1,6M
+7% vs 2024
EBITDA margin
6.6%
+69% vs 2024
Equity ratio
55.2%
Financial strength
Net profit 2025
SEK 83K
+175% vs 2024
| Revenue | SEK 1,6M | +7% |
| EBITDA | SEK 106K | +69% |
| Net profit | SEK 83K | +175% |
| Total assets | SEK 683K | +12% |
| Equity | SEK 377K | +28% |
| Employees | 2 | — |
Legal name
Noventus AB
Org number
5565638847
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
13 januari 1999
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Granqvist, Reimo Thorbjörn
Company purpose
Bolaget skall bedriva sjukgymnastikrörelse och försäljning av produkter och tjänster som är relaterade därtill samt i övrigt bedriva i enlighet med det sagda förenlig verksamhet.
Address
Henry Dunkers Plats 4
Phone
+4642131260
Email
info@klinikennoventus.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 743 | 1 547 | 1 600 | 1 505 | 1 614 |
| Staff expenses | — | — | −861 | −957 | −996 |
| EBITDA | 233 | 167 | 306 | 63 | 106 |
| Depreciation & amort. | −22 | −22 | −22 | −22 | — |
| EBIT | 211 | 145 | 283 | 40 | 106 |
| Net financials | −3 | −3 | −3 | −2 | −2 |
| Profit before tax | 208 | 142 | 280 | 39 | 105 |
| Tax | −45 | −30 | −58 | −8 | −22 |
| Net profit | 163 | 112 | 222 | 30 | 83 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 559 | 661 | 695 | 609 | 683 |
| Equity | 280 | 242 | 464 | 294 | 377 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 110 | 250 | 62 | 145 | 136 |
| Total debt | 110 | 250 | 62 | 145 | 136 |
EBITDA margin
6.6%
This company
15.8%
Market median
-58% vs market
20212025
Equity ratio
55.2%
This company
38.2%
Market median
+45% vs market
20212025
Return on equity
22.0%
This company
18.4%
Market median
+20% vs market
20212025
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20212025
Asset turnover
2.36×
This company
1.12×
Market median
+111% vs market
20212025
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Noventus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Reimo Thorbjörn Granqvist | Chairman | 0 companies |
| Mathias Lennart Granqvist | Deputy Board Member | 0 companies |
| Eila Ritva Annikki Granqvist | Board of Directors | 0 companies |